Work

AT (doxorubicin-Taxol) versus AC (doxorubicin-cyclophosphamide) as first line chemotherapy in metastatic breast cancer (MBC): A phase III study. (originally presented at ASCO 2000. Abstract 282)

Year: 2000

Type: conference-paper

Source: Ghent University Academic Bibliography (Ghent University)

Authors: M. Piccart, T. Čufer, P.F. Bruning, RE Coleman, Ha Calvert, Teresa Gamucci, C.J. Twelves, Luc Duchateau, Laura Biganzoli, E Donato-Di Paola, Carmen Yagüe, Ron Epelbaum

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2579768621

FWCI: 31.32

Cites:

Cited by: 15

Related to: 10